⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27617871 | 0.70 | — | — | |
| SCHEMBL28018128 | 0.67 | PARP1 (0.43) | — | |
| SCHEMBL14415970 | 0.66 | HRH4 (0.44) | — | |
| SCHEMBL26068453 | 0.66 | ALDH1A1 (0.43) | — | |
| SCHEMBL14857108 | 0.64 | HRH4 (0.43) | — | |
| SCHEMBL12261150 | 0.63 | HRH4 (0.39) | — | |
| SCHEMBL7194641 | 0.61 | IDO1 (0.59) | — | |
| Hydrochloric Acid SCHEMBL27554053 | 0.61 | — | — | |
| Hydrochloric Acid SCHEMBL27259157 | 0.61 | — | — | |
| SCHEMBL1801743 | 0.61 | HRH3 (0.46) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 65 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10224485-B2 | Process for preparing a crystalline organic semiconductor material | BASF SE (DE) | 2019-03-05 | — | — | US | claimed |
| US-20170012208-A1 | ORGANIC SEMICONDUCTOR FORMULATIONS | USINVEST LLC | 2017-01-12 | — | — | US | claimed |
| CN-102124002-B | Novel phenylimidazole derivatives as pde10a enzyme inhibitors | LUNDBECK & CO AS H | 2014-06-25 | — | — | CN | claimed |
| CN-102124002-A | Novel phenylimidazole derivatives as pde10a enzyme inhibitors | LUNDBECK & CO AS H | 2011-07-13 | — | — | CN | claimed |
| EP-4720162-A1 | MAIN CHAIN CATIONIC OLIGO(IMIDAZOLIUM) FORMS N-HETEROCYCLIC CARBENE FOR EFFECTIVE BACTERIAL KILLING IN COMPLEX ENVIRONMENT | Nanyang Technological University (SG) | 2026-04-08 | — | — | EP | disclosed |
| EP-4650345-A1 | HETEROCYCLIC COMPOUND AND USE THEREOF IN MEDICINE | Kangbaida (Sichuan) Biotechnology Co., Ltd. (CN) | 2025-11-19 | — | — | EP | disclosed |
| WO-2025236011-A1 | COMPOSITIONS FOR PHOSPHOROUS-AZOLE EXCHANGE CHEMISTRY AND USE THEREOF TO TARGET FUNCTIONAL PROTEIN SITES | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2025-11-13 | — | — | WO | disclosed |
| US-20250098679-A1 | HERBICIDAL PYRIDONE DERIVATIVES | SYNGENTA CROP PROTECTION AG (CH) | 2025-03-27 | — | — | US | disclosed |
| WO-2025043225-A2 | DEGRADERS OF CYCLIN-DEPENDENT KINASE 2 | GENENTECH, INC. (US) | 2025-02-27 | — | — | WO | disclosed |
| WO-2024248739-A1 | MAIN CHAIN CATIONIC OLIGO(IMIDAZOLIUM) FORMS N-HETEROCYCLIC CARBENE FOR EFFECTIVE BACTERIAL KILLING IN COMPLEX ENVIRONMENT | NANYANG TECHNOLOGICAL UNIVERSITY (SG) | 2024-12-05 | — | — | WO | disclosed |
| EP-4448509-A1 | HERBICIDAL PYRIDONE DERIVATIVES | Syngenta Crop Protection AG (CH) | 2024-10-23 | — | — | EP | disclosed |
| WO-2024149242-A1 | HETEROCYCLIC COMPOUND AND USE THEREOF IN MEDICINE | 成都百裕制药股份有限公司 | 2024-07-18 | — | — | WO | disclosed |
| EP-2213668-A2 | Imidazoles as aldosterone synthase inhibitors | Novartis AG (CH) | 2010-08-04 | — | — | EP | disclosed |
| US-20100048562-A1 | ORGANIC COMPOUNDS | NOVARTIS AG (CH) | 2010-02-25 | — | — | US | disclosed |
| US-20100048562-A1 | ORGANIC COMPOUNDS | NOVARTIS AG (CH) | 2010-02-25 | — | — | US | disclosed |
| US-20100048562-A1 | ORGANIC COMPOUNDS | NOVARTIS AG (CH) | 2010-02-25 | — | — | US | disclosed |
| CN-101605777-A | Imidazoles as aldosterone synthase inhibitors | NOVARTIS AG (CH) | 2009-12-16 | — | — | CN | disclosed |
| EP-2094680-A2 | IMIDAZOLES AS ALDOSTERONE SYNTHASE INHIBITORS | Novartis AG (CH) | 2009-09-02 | — | — | EP | disclosed |
| WO-2008076336-A2 | IMIDAZOLES AS ALDOSTERONE SYNTHASE INHIBITORS | NOVARTIS AG (CH) | 2008-06-26 | — | — | WO | disclosed |
| WO-2008076336-A2 | IMIDAZOLES AS ALDOSTERONE SYNTHASE INHIBITORS | NOVARTIS AG (CH) | 2008-06-26 | — | — | WO | disclosed |